Navigation Links
Phase III study finds investigational agent empagliflozin significantly reduced blood glucose in adults with type 2 diabetes and impaired kidney function
Date:6/22/2013

RIDGEFIELD, Conn. and INDIANAPOLIS, June 22, 2013 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (NYSE: LLY) today announced results of a 52-week phase III clinical trial of the investigational agent empagliflozin*, which showed statistically significant reductions in HbA1c (average blood glucose) at week 24 with the addition of empagliflozin to existing oral antihyperglycemic therapy in adults with type 2 diabetes (T2D) and mild to moderate kidney impairment (eGFR>/=60 to <90 ml/min/1.73 m2 and eGFR>/=30 to <60 ml/min/1.73 m2).1

Empagliflozin is a member of the sodium glucose co-transporter-2 (SGLT2) inhibitor class of compounds, and is being investigated for the reduction of blood glucose levels in adults with T2D. The emerging SGLT2 inhibitor class removes excess glucose through the urine by blocking glucose re-absorption by the kidney.

Results from the study, presented at the American Diabetes Association 73rd Scientific Sessions®, also demonstrated a significant reduction in body weight and blood pressure with empagliflozin versus placebo in patients with mild to moderate kidney impairment.1 Adverse events (AEs) were reported in 79.6 percent, 75.4 percent and 72.7 percent of patients at 24 weeks with empagliflozin 10 mg, empagliflozin 25 mg and placebo, respectively.

"We are encouraged by the data from this phase III study," said Christophe Arbet-Engels, MD, PhD, vice president, metabolic-clinical development and medical affairs, Boehringer Ingelheim Pharmaceuticals, Inc. "Many people with type 2 diabetes also are impacted by renal impairment. Through the Boehringer Ingelheim and Lilly Diabetes alliance, we are using our collective knowledge to find
'/>"/>

SOURCE Eli Lilly and Company; Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Phase III studies show linagliptin improved blood glucose control in Asian adults with type 2 diabetes
2. Phase III data show investigational compound empagliflozin significantly reduced blood glucose in adults with type 2 diabetes
3. Follow-up Phase II Data Analysis Adds to Body of Evidence for Investigational Novel Basal Insulin, LY2605541
4. Phase III data show significant reduction in blood glucose with investigational compound empagliflozin added to metformin or metformin plus sulfonylurea in adults with type 2 diabetes
5. Sanofi Announces Positive Phase 3 Data for Once-Daily Lixisenatide for Type 2 Diabetes
6. Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine
7. Safinamide Phase III Study Results Presented at 2013 MDS Meeting
8. Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinsons Disease
9. Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder
10. AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting
11. Updated Results of Two Phase 2 Ibrutinib Studies in Patients with Mantle Cell Lymphoma or Diffuse Large B-cell Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)...  The American Diabetes Association is recommending a ... with diabetes and that all people with diabetes ... in keeping with recent changes to guidelines for ... of Cardiology (ACC) and American Heart Association (AHA). ... changes to the Association,s annual revised Standards of ...
(Date:12/22/2014)... , Dec. 22, 2014  CytoSorbents Corporation ... its CytoSorb® blood purification technology to help fight ... in 28 countries worldwide, today announced the appointment ... MD, FACS, as its Senior Vice President of ... Dr. Di Russo is an ...
(Date:12/22/2014)... 22, 2014 Research and Markets ... the "Investment Analysis of the US Medical ... http://photos.prnewswire.com/prnh/20130307/600769 ... medical device sector identifies the key trends and ... investments, and mergers and acquisitions. The ...
Breaking Medicine Technology:New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5Investment Analysis of the US Medical Device Sector 2
... 18, 2011 Today, patient support group Mended Hearts, in ... launched the Stent Hub – an online resource for acute ... stenting (also known as percutaneous coronary intervention, or PCI), as ... many ACS patients who receive a stent have the impression ...
... WAKEFIELD, Mass., Jan. 18, 2011 Paul Pescatello has ... Association (NEBA) at the organization,s annual meeting. ... biotech associations, companies, academic institutions, and other organizations in ... to support and grow the biotechnology industry in the ...
Cached Medicine Technology:New Online Resource Available Specifically for Patients and Their Caregivers Following a Heart Stent Procedure 2New Online Resource Available Specifically for Patients and Their Caregivers Following a Heart Stent Procedure 3Pescatello Elected to Head New England Biotech Association in 2011-12 2
(Date:12/24/2014)... HealthDay Reporter TUESDAY, Dec. 23, ... beds and booths, although this risky behavior remains popular with more ... In 2013, about 20 percent of high school girls and 5 ... indoor tanning at least once in the previous year, according to ... girls and nearly 7 percent of boys who had done so ...
(Date:12/22/2014)... December 22, 2014 As part ... senior care service in San Diego and ... of its senior care team with ongoing online ... Golden Care is provided by Caregiverlist®. Caregiverlist® ... caregivers with the most reliable eldercare options, highest ...
(Date:12/22/2014)... Coral Gables, FL (PRWEB) December 22, 2014 ... head lice removal service , Lice Troopers, with its new ... established in southern Florida, takes the hassle out of dealing ... removal services in one of their two salon clinic locations ... home or other location. , The decision to expand developed ...
(Date:12/22/2014)... On December 22, 2014, My Positive Perspective host ... an episode to celebrate Christmas. At the beginning of ... important to you that we all appreciate and recognize ... respect who Jesus was. I think sometimes we forget ... means that on Jesus’ birthday we remember that justice, ...
(Date:12/22/2014)... and state health officials are investigating a listeria outbreak ... four people and sickened 28 others in 10 states. ... caramel apples until more information becomes available, the U.S. ... news release. As of Dec. 18, a total ... strains of the bacteria Listeria monocytogenes . Of ...
Breaking Medicine News(10 mins):Health News:Fewer U.S. Teens in Tanning Salons, Study Finds 2Health News:Fewer U.S. Teens in Tanning Salons, Study Finds 3Health News:Golden Care Partners with Nationally Recognized Caregiver Training Service 2Health News:Professional In-Home All-Natural Lice Removal Service Expands to Coral Gables and surrounding areas. 2Health News:My Positive Perspective Celebrates Christmas With an Event to Celebrate the Birthday of Jesus 2Health News:CDC Warns of Listeria Danger From Caramel Apples 2
... NEW YORK, June 24 According to the ... from diabetes,asthma and other chronic conditions. The medical care ... the nation,s $2 trillion medical care,costs. And as the ... its medical bills are expected to spiral further out ...
... a latency period of 10-50,years, and with millions of ... of this life ending disease continue,to disrupt families and ... leadership, members of Congress and three guest speakers,who will ... The press conference will be held on the ...
... to Reduce ... Impact of Diagnosed Health Conditions, LAGUNA HILLS, Calif., ... tasty, satisfying foods that help people prevent and,manage Diabetes ... snack bars in over 200 Southern California Ralph,s,grocery stores. ...
... 2008) The American Academy of Cosmetic Surgery has released ... opinions on medical spas. Findings revealed that millennials, those ... these facilities. Yet half of those women are compromising ... , Women ages 18-34 were more than three times as ...
... Brompton and Harefield NHS Trust,s Leadership Role in the Treatment ... ... Stereotaxis, Inc. (Nasdaq:,STXS) announced that British Prime Minister Gordon Brown presided ... lab at,Royal Brompton Hospital in London. The new lab features Stereotaxis ...
... (NYSE:,HRC) today announced the signing of a distribution ... agreement will enhance selling,efforts for Hill-Rom,s product The ... care facilities within the United States., "We ... said Kim,Dennis, group vice president, Post Acute Care ...
Cached Medicine News:Health News:Healthcare Experts Discuss Current and Future Challenges of Chronic Care on NewTalk 2Health News:Healthcare Experts Discuss Current and Future Challenges of Chronic Care on NewTalk 3Health News:Faces of Mesothelioma; Meso Foundation Press Conference with Families and Patients 2Health News:Heart Disease and Diabetes Finally Meet Their Match With Delicious New Snack Bars From WatchDog Nutrition(TM) 2Health News:London's Royal Brompton Hospital Opens New Electrophysiology Lab With State of the Art Magnetic Technology to Treat Arrhythmias 2Health News:London's Royal Brompton Hospital Opens New Electrophysiology Lab With State of the Art Magnetic Technology to Treat Arrhythmias 3Health News:Hill-Rom Announces Agreement With Tri-anim to Enhance Distribution Channels for The Vest(R) System in U.S. Hospitals & Long-Term Care Facilities 2Health News:Hill-Rom Announces Agreement With Tri-anim to Enhance Distribution Channels for The Vest(R) System in U.S. Hospitals & Long-Term Care Facilities 3Health News:Hill-Rom Announces Agreement With Tri-anim to Enhance Distribution Channels for The Vest(R) System in U.S. Hospitals & Long-Term Care Facilities 4
Pneumatic micro sagittal saw, 30k cpm, available with various hose connector styles....
... power line from MicroAire. Our new ... electric instruments, offering the ultimate in ... has always wanted with the security ... Power Master reciprocating saw, Available with ...
... The 7600 Oscillating Saw offers ... osteotomies, thanks to its 14.4V ... cutting head may be rotated ... in any plane and will ...
... Brasseler USAs Large Bone Power System ... offers new technological advancements. The truly innovative ... power pack, which is comprised of the ... handpiece contains only mechanical components, which provides ...
Medicine Products: